CONDENSED BALANCE SHEETS - USD ($)	Jun. 30, 2025	Dec. 31, 2024
Current Assets:
Cash and cash equivalents	$ 29,757,328	$ 38,339,762
Prepaids and other current assets	3,670,319	5,968,666
Total current assets	33,427,647	44,308,428
Fixed assets, net	24,908	38,588
Total assets	33,452,555	44,347,016
Current liabilities:
Accounts payable	931,344	1,588,128
Accrued expenses	2,838,685	1,388,060
Deferred collaboration revenue	731,075	848,286
Total current liabilities	4,501,104	3,824,474
Deferred collaboration revenue	641,158	945,447
Total liabilities	5,142,262	4,769,921
Commitments and contingencies (Note 6)
Stockholders' equity:
Series A convertible preferred stock, $0.0001 par value: 10,000,000 shares authorized, none issued or outstanding as of June 30, 2025 or December 31, 2024
Common stock, $0.0001 par value; 200,000,000 shares authorized; 16,724,998 and 16,707,441 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively	1,673	1,671
Additional paid-in capital	82,447,524	80,312,594
Accumulated deficit	(54,138,904)	(40,737,170)
Total stockholders' equity	28,310,293	39,577,095
Total liabilities and stockholders' equity	$ 33,452,555	$ 44,347,016

Deferred collaboration revenue.

No definition available.

Name:	coya_DeferredCollaborationRevenue
Namespace Prefix:	coya_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).